图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY

ISSN:2169-1401
出版频率:Continuous publication
出版社:TAYLOR & FRANCIS LTD, 2-4 PARK SQUARE, MILTON PARK, ABINGDON, England, OXON, OX14 4RN
  出版社网址:http://informahealthcare.com/
期刊网址:http://informahealthcare.com/journal/anb
影响因子:5.678
主题范畴:BIOTECHNOLOGY & APPLIED MICROBIOLOGY;    ENGINEERING, BIOMEDICAL;    MATERIALS SCIENCE, BIOMATERIALS

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal
Aims & Scope


2011 Impact Factor: 0.975
5-year Impact Factor: 1.034
Ranking: 123/157 (Biotechnology and Applied Microbiology),
53/72 (Biomedical Engineering), 23/25 (Biomaterials, Materials Science)

©Thomson Reuters, Journal Citation Reports® 2011


Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics: 

  • artificial cells
  • blood substitutes
  • nanotechnology, nanobiotecnology, nanomedicine
  • tissue engineering
  • stem cells
  • bioencapsulation
  • microencapsulation and nanoencapsulation
  • microparticles and nanoparticles
  • liposomes
  • cell therapy and gene therapy
  • enzyme therapy
  • drug delivery systems
  • biodegradable and biocompatible polymers for scaffolds and carriers
  • biosensors
  • immobilized enzymes and their uses
  • other biotechnological and nanobiotechnological approaches

Rapid progress in modern research cannot be carried out in isolation and is based on the combined use of the different novel approaches. The interdisciplinary research involving novel approaches, as discussed above, has revolutionized this field resulting in rapid developments. This journal serves to bring these different, modern and futuristic approaches together for the academic, clinical and industrial communities to allow for even greater developments of this highly interdisciplinary area.




Abstracting & Indexing

Artificial Cells, Blood Substitutes, and Biotechnology is indexed/abstracted in: Academic Search Complete, Biochemistry and Biophysics Citation Index, Biological Abstracts, Biomedical Reference Collection: Comprehensive, BIOSIS Full Coverage Shared, BIOSIS Previews, Biotechnology Abstracts, Biotechnology Citation Index, COMPENDEX, EMBASE, EMBIOLOGY, Journal Citation Reports/Science Edition, Materials Science Citation Index, PubMed/MedLine, Science Citation Index, SciSearch, SCOPUS, SIIC.




Read More: http://informahealthcare.com/page/abb/Description#Instructions

Aims & Scope

In 2013, we plan to change the name of this journal to Artificial Cells, Nanomedicine and Biotechnology. This will truly reflect the aims and scope of this journal, and to cover the frontiers of interdisciplinary research, and clinical and industrial applications.

2012 Impact Factor: 0.854
5-year Impact Factor:
0.826
Ranking: 129/159 (Biotechnology and Applied Microbiology),
62/79 (Biomedical Engineering), 22/27 (Biomaterials, Materials Science)

©Thomson Reuters, Journal Citation Reports® 2013


Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics: 

  • artificial cells
  • blood substitutes and oxygen therapeutics
  • nanotechnology, nanobiotecnology, nanomedicine
  • tissue engineering
  • stem cells
  • bioencapsulation
  • microencapsulation and nanoencapsulation
  • microparticles and nanoparticles
  • liposomes
  • cell therapy and gene therapy
  • enzyme therapy
  • drug delivery systems
  • biodegradable and biocompatible polymers for scaffolds and carriers
  • biosensors
  • immobilized enzymes and their uses
  • other biotechnological and nanobiotechnological approaches

Rapid progress in modern research cannot be carried out in isolation and is based on the combined use of the different novel approaches. The interdisciplinary research involving novel approaches, as discussed above, has revolutionized this field resulting in rapid developments. This journal serves to bring these different, modern and futuristic approaches together for the academic, clinical and industrial communities to allow for even greater developments of this highly interdisciplinary area.


Abstracting & Indexing

Artificial Cells, Nanomedicine, and Biotechnology is indexed/abstracted in: Academic Search Complete, Biochemistry and Biophysics Citation Index, Biological Abstracts, Biomedical Reference Collection: Comprehensive, BIOSIS Full Coverage Shared, BIOSIS Previews, Biotechnology Abstracts, Biotechnology Citation Index, COMPENDEX, EMBASE, EMBIOLOGY, Journal Citation Reports/Science Edition, Materials Science Citation Index, PubMed/MedLine, Science Citation Index, SciSearch, SCOPUS, SIIC.


Instructions to Authors
ABB_IFAs.pdf

Editorial Board

Editorial Staff

Managing Editor: Sam Cunningham


Production Editor: Emily Willis




Read More: http://informahealthcare.com/page/anb/Description
Aims & Scope


2011 Impact Factor: 0.975
5-year Impact Factor: 1.034
Ranking: 123/157 (Biotechnology and Applied Microbiology),
53/72 (Biomedical Engineering), 23/25 (Biomaterials, Materials Science)

©Thomson Reuters, Journal Citation Reports® 2011


Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics: 

  • artificial cells
  • blood substitutes
  • nanotechnology, nanobiotecnology, nanomedicine
  • tissue engineering
  • stem cells
  • bioencapsulation
  • microencapsulation and nanoencapsulation
  • microparticles and nanoparticles
  • liposomes
  • cell therapy and gene therapy
  • enzyme therapy
  • drug delivery systems
  • biodegradable and biocompatible polymers for scaffolds and carriers
  • biosensors
  • immobilized enzymes and their uses
  • other biotechnological and nanobiotechnological approaches

Rapid progress in modern research cannot be carried out in isolation and is based on the combined use of the different novel approaches. The interdisciplinary research involving novel approaches, as discussed above, has revolutionized this field resulting in rapid developments. This journal serves to bring these different, modern and futuristic approaches together for the academic, clinical and industrial communities to allow for even greater developments of this highly interdisciplinary area.




Abstracting & Indexing

Artificial Cells, Blood Substitutes, and Biotechnology is indexed/abstracted in: Academic Search Complete, Biochemistry and Biophysics Citation Index, Biological Abstracts, Biomedical Reference Collection: Comprehensive, BIOSIS Full Coverage Shared, BIOSIS Previews, Biotechnology Abstracts, Biotechnology Citation Index, COMPENDEX, EMBASE, EMBIOLOGY, Journal Citation Reports/Science Edition, Materials Science Citation Index, PubMed/MedLine, Science Citation Index, SciSearch, SCOPUS, SIIC.




Read More: http://informahealthcare.com/page/abb/Description#Instructions

Editorial Staff

Managing Editor: Sam Cunningham

Production Editor: Emily Willis



 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2005-2006 武汉大学图书馆版权所有